SomaLogic revolutionizing precision medicine and powering proteomics
SomaLogic – powered by an industry-leading technology platform and one of the largest clinical proteomic databases in the world – is a global leader in proteomics.
The proteomics field is enabling researchers to find disease biomarkers for both diagnostics and therapeutic targets – and is growing fast. SomaLogic is helping the field reach its potential with a unique platform for measuring protein levels: the SomaScan® Assay, based on Slow Off-Rate Modified Aptamers (SOMAmer® reagents). The SomaScan Assay provides 7,000 highly reproducible measurements of circulating proteins from a single sample of plasma, serum, urine, or a variety of other sample types. The SomaScan Assay uses proprietary aptamer-based technology to offer a number of benefits within this field.
Key topics included
Whitepaper protein Quantitative Trait Locus (pQTL): The missing link between genes and disease: Discovery of protein quantitative trait loci using high-plex protein profiling.
Neurology: The SomaScan® Assay enables discovery of blood based biomarkers in neurodegenerative diseases.
Cardiovascular Diseases: Detection of low-abundance serum proteins associated with cardiovascular diseases for prognostic purposes.
Webinar (On Demand): Liquid health check – plasma protein patterns as comprehensive indicators of health.
Webinar (On Demand): The liquid liver biopsy – characterizing NASH and NAFLD with serum protein biomarkers.
SomaScan Assay v4.1: The SomaScan Platform is a powerful tool with applications in scientific research and health and wellness. This technical note provides background on the platform itself, as well as performance metrics for the SomaScan Assay v4.1.
Brochure: Assessing pre-analytical variation for more accurate proteomic analysis.
To read SomaLogic’s privacy policy Click Here